Portfolio Companies News
-
January 13, 2021GenSight Biologics Announces Public...
Bilateral improvement in visual acuity from a unilateral injection of gene therapy – consistent with REVERSE trial findings Significant improvement against visual acuity nadir Paris, France, January 13, 2021, 7:30 am CET – GenSight Biologics (Euronext: SIGHT, I... read more
-
January 7, 2021CARISMA Therapeutics Completes Seri...
PHILADELPHIA, Jan. 7, 2021 /PRNewswire/ -- CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today that it has completed its Series B equity financing providing for gross proceeds of $47 million, bringing CARISMA'... read more
-
January 6, 2021Spruce Biosciences Provides Corpora...
-CAHmelia Adult Classic CAH Program Underway in U.S. and Europe- -Initiation of Phase 2 Pediatric Classic CAH Program Anticipated in Second Half of 2021- -Initiation of Phase 2 Polycystic Ovary Syndrome Program Anticipated in Second Half of 2021- -New Patent Issuance Extends Tildacerfont Patent E... read more
-
January 6, 2021Strongbridge Biopharma plc Announce...
Expects to Report KEVEYIS® (dichlorphenamide) Fourth Quarter 2020 Revenue of Approximately $8.2 Million and Full-Year 2020 Revenue of Approximately $30.7 Million, a 41.5 Percent Increase over 2019 Revenue of $ $21.7 Million ~ ~ Targets Full-Year 2021 KEVEYIS® (dichlorphenamide) Revenue G... read more
-
January 6, 2021Targovax grants IOVaxis 3 months ex...
COVID-19 have caused delays to submission and processing of the regulatory application to initiate clinical development in China Due to the unforeseen delays, Targovax has extended the term of IOvaxis´s license option by 3 months, otherwise the agreement remains unchanged Oslo, Norway 6 ... read more
HealthCap Info
-
November 03, 2020Q3 2020 General Market Overview
Facts
-
118
Since the start in 1996, HealthCap funds have invested in 118 portfolio companies.
-
46
46 of the portfolio companies have been taken public on nine different markets.
-
26
26 of the portfolio companies’ pharmaceutical products have been approved for marketing.
-
12
Unicorn Factory
Since the start in 1996, HealthCap has helped build 12 companies with a valuation of USD 1 billion or more.
2 days ago
8 days ago